Crizotinib Impurity 52 | CAS 2509276-75-7 - Request Quote
Crizotinib Impurity 52
| SZ CAT No: | SZ-C148059 |
| CAS No | 2509276-75-7 |
| Mol.F. | C13H12ClFN2O |
| Mol.Wt. | 266.7 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Crizotinib Impurity 52 is chemically (R)-3-(1-(2-Chloro-3-fluorophenyl)ethoxy)pyridin-2-amine. Crizotinib Impurity 52 is supplied with detailed characterization data compliant with regulatory guideline. Crizotinib Impurity 52 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Crizotinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 2509276-75-7
Purchase 2509276-75-7
Order 2509276-75-7
Enquire 2509276-75-7
price of 2509276-75-7
2509276-75-7 Supplier
2509276-75-7 Manufacturer
2509276-75-7 Exporter
buy high quality Crizotinib Impurity 52
Purchase Crizotinib Impurity 52
Crizotinib Impurity 52 suppliers
Crizotinib Impurity 52 manufacturers
Crizotinib Impurity 52 price
Order Crizotinib Impurity 52
Enquire Crizotinib Impurity 52
Crizotinib Impurity 52 cost
Crizotinib Impurity 52 Supplier
Crizotinib Impurity 52 Distributor
Crizotinib Impurity 52 for Method Validation
Crizotinib Reference Standard
Crizotinib Impurity 52 for ANDA Filing
Crizotinib Impurity 52 for Forced Degradation Studies
Crizotinib Impurity 52 Identification Standards
Crizotinib Impurity 52 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.